LFA-1 and ICAM-1 expression induced during melanoma-endothelial cell co-culture favors the transendothelial migration of melanoma cell lines in vitro

BMC Cancer

Volumn 12, Issue , 2012, Pages

  Ghislin, Stephanie ^a   Obino, Dorian ^a   Middendorp, Sandrine ^a   Boggetto, Nicole ^b   Alcaide Loridan, Catherine ^a   Deshayes, Frederique ^a  

^a INSTITUT JACQUES MONOD   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

HUVEC; ICAM 1; LFA 1; Melanoma; Metastasis; Transendothelial migration

Indexed keywords

CD18 ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1;

ANTIBODY DETECTION; ARTICLE; CELL MIGRATION; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOTHELIUM CELL; EPIFLUORESCENCE MICROSCOPY; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOMODULATION; LIPOPHILICITY; MELANOMA CELL; PROTEIN EXPRESSION; T LYMPHOCYTE; UPREGULATION;

ANTIGENS, CD11A; ANTIGENS, CD18; CELL COMMUNICATION; CELL LINE, TUMOR; COCULTURE TECHNIQUES; CYTOKINES; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; MELANOMA; MICROSCOPY, FLUORESCENCE; POLYMERASE CHAIN REACTION; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION; TUMOR CELLS, CULTURED;

EID: 84867027385     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-12-455     Document Type: Article

References (45)

1. Bhatia S, Tykodi SS, Thompson JA. Treatment of metastatic melanoma: an overview. Oncology (Williston Park) 2009, 23:488-496.
2. Strell C, Entschladen F. Extravasation of leukocytes in comparison to tumor cells. Cell Commun. Signal 2008, 6:10. 10.1186/1478-811X-6-10, 2627905, 19055814.
3. Springer TA. Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration. Annu Rev Physiol 1995, 57:827-872. 10.1146/annurev.ph.57.030195.004143, 7778885.
4. Kobayashi H, Boelte KC, Lin PC. Endothelial cell adhesion molecules and cancer progression. Curr Med Chem 2007, 14:377-386. 10.2174/092986707779941032, 17305540.
5. Butcher EC. Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell 1991, 67:1033-1036. 10.1016/0092-8674(91)90279-8, 1760836.
6. Jung U, Norman KE, Scharffetter-Kochanek K, Beaudet AL, Ley K. Transit time of leukocytes rolling through venules controls cytokine-induced inflammatory cell recruitment in vivo. J Clin Invest 1998, 102:1526-1533. 10.1172/JCI119893, 509002, 9788965.
7. Dunne JL, Ballantyne CM, Beaudet AL, Ley K. Control of leukocyte rolling velocity in TNF-alpha-induced inflammation by LFA-1 and Mac-1. Blood 2002, 99:336-341. 10.1182/blood.V99.1.336, 11756189.
8. Dustin ML, Rothlein R, Bhan AK, Dinarello CA, Springer TA. Induction by IL 1 and interferon-gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J Immunol 1986, 137:245-254.
9. Roebuck KA, Finnegan A. Regulation of intercellular adhesion molecule-1 (CD54) gene expression. J Leukoc Biol 1999, 66:876-888.
10. Rothlein R, Dustin ML, Marlin SD, Springer TA. A human intercellular adhesion molecule (ICAM-1) distinct from LFA-1. J Immunol 1986, 137:1270-1274.
11. Ding ZM, Babensee JE, Simon SI, Lu H, Perrard JL, Bullard DC, Dai XY, Bromley SK, Dustin ML, Entman ML, Smith CW, Ballantyne CM. Relative contribution of LFA-1 and Mac-1 to neutrophil adhesion and migration. J Immunol 1999, 163:5029-5038.
12. Arfors KE, Lundberg C, Lindbom L, Lundberg K, Beatty PG, Harlan JM. A monoclonal antibody to the membrane glycoprotein complex CD18 inhibits polymorphonuclear leukocyte accumulation and plasma leakage in vivo. Blood 1987, 69:338-340.
13. Fraemohs L, Koenen RR, Ostermann G, Heinemann B, Weber C. The functional interaction of the beta 2 integrin lymphocyte function-associated antigen-1 with junctional adhesion molecule-A is mediated by the I domain. J Immunol 2004, 173:6259-6264.
14. Ostermann G, Weber KSC, Zernecke A, Schröder A, Weber C. JAM-1 is a ligand of the beta(2) integrin LFA-1 involved in transendothelial migration of leukocytes. Nat Immunol 2002, 3:151-158.
15. Williams LA, Martin-Padura I, Dejana E, Hogg N, Simmons DL. Identification and characterisation of human Junctional Adhesion Molecule (JAM). Mol Immunol 1999, 36:1175-1188. 10.1016/S0161-5890(99)00122-4, 10698320.
16. Wojcikiewicz EP, Koenen RR, Fraemohs L, Minkiewicz J, Azad H, Weber C, Moy VT. LFA-1 binding destabilizes the JAM-A homophilic interaction during leukocyte transmigration. Biophys J 2009, 96:285-293. 10.1529/biophysj.108.135491, 2710021, 18849408.
17. Tatsumi T, Shimazaki C, Goto H, Araki S, Sudo Y, Yamagata N, Ashihara E, Inaba T, Fujita N, Nakagawa M. Expression of adhesion molecules on myeloma cells. Jpn J Cancer Res 1996, 87:837-842. 10.1111/j.1349-7006.1996.tb02108.x, 8797890.
18. Gulubova MV. Expression of cell adhesion molecules, their ligands and tumour necrosis factor alpha in the liver of patients with metastatic gastrointestinal carcinomas. Histochem J 2002, 34:67-77. 10.1023/A:1021304227369, 12365802.
19. Liang S, Fu C, Wagner D, Guo H, Zhan D, Dong C, Long M. Two-dimensional kinetics of beta 2-integrin and ICAM-1 bindings between neutrophils and melanoma cells in a shear flow. Am J Physiol Cell Physiol 2008, 294:C743-753. 10.1152/ajpcell.00250.2007, 2678683, 18199704.
20. Lynam E, Sklar LA, Taylor AD, Neelamegham S, Edwards BS, Smith CW, Simon SI. Beta2-integrins mediate stable adhesion in collisional interactions between neutrophils and ICAM-1-expressing cells. J Leukoc Biol 1998, 64:622-630.
21. Slattery MJ, Dong C. Neutrophils influence melanoma adhesion and migration under flow conditions. Int J Cancer 2003, 106:713-722. 10.1002/ijc.11297, 2778842, 12866031.
22. Ghislin S, Obino D, Middendorp S, Boggetto N, Alcaide-Loridan C, Deshayes F. Junctional adhesion molecules are required for melanoma cell lines transendothelial migration in vitro. Pigment Cell Melanoma Res 2011, 24:504-511. 10.1111/j.1755-148X.2011.00856.x, 21466663.
23. Wung BS, Ni CW, Wang DL. ICAM-1 induction by TNFalpha and IL-6 is mediated by distinct pathways via Rac in endothelial cells. J Biomed Sci 2005, 12:91-101. 10.1007/s11373-004-8170-z, 15864742.
24. Bernasconi S, Matteucci C, Sironi M, Conni M, Colotta F, Mosca M, Colombo N, Bonazzi C, Landoni F, Corbetta G. Effects of granulocyte-monocyte colony-stimulating factor (GM-CSF) on expression of adhesion molecules and production of cytokines in blood monocytes and ovarian cancer-associated macrophages. Int J Cancer 1995, 60:300-307. 10.1002/ijc.2910600304, 7829234.
25. Altomonte M, Colizzi F, Esposito G, Maio M. Circulating intercellular adhesion molecule 1 as a marker of disease progression in cutaneous melanoma. N Engl J Med 1992, 327:959.
26. Harning R, Mainolfi E, Bystryn JC, Henn M, Merluzzi VJ, Rothlein R. Serum levels of circulating intercellular adhesion molecule 1 in human malignant melanoma. Cancer Res 1991, 51:5003-5005.
27. Ciotti P, Imro A, Scudeletti M, Rainero ML, Defferrari R, Ghiorzo P, Indiveri F, Bianchi-Scarrà G. MEL-P, a GM-CSF-producing human melanoma cell line. Melanoma Res 1996, 6:203-213. 10.1097/00008390-199606000-00003, 8819123.
28. Alon R, Ley K. Cells on the run: shear-regulated integrin activation in leukocyte rolling and arrest on endothelial cells. Curr Opin Cell Biol 2008, 20:525-532. 10.1016/j.ceb.2008.04.003, 18499427.
29. Kohn EC, Hollister GH, DiPersio JD, Wahl S, Liotta LA, Schiffmann E. Granulocyte-macrophage colony-stimulating factor induces human melanoma-cell migration. Int J Cancer 1993, 53:968-972.
30. Burns S, Hardy SJ, Buddle J, Yong KL, Jones GE, Thrasher AJ. Maturation of DC is associated with changes in motile characteristics and adherence. Cell Motil Cytoskeleton 2004, 57:118-132. 10.1002/cm.10163, 14691951.
31. Hart IR. New evidence for tumour embolism as a mode of metastasis. J Pathol 2009, 219:275-276. 10.1002/path.2616, 19768739.
32. Quax PH, van Muijen GN, Weening-Verhoeff EJ, Lund LR, Danø K, Ruiter DJ, Verheijen JH. Metastatic behavior of human melanoma cell lines in nude mice correlates with urokinase-type plasminogen activator, its type-1 inhibitor, and urokinase-mediated matrix degradation. J Cell Biol 1991, 115:191-199. 10.1083/jcb.115.1.191, 2289921, 1918136.
33. Meissauer A, Kramer MD, Hofmann M, Erkell LJ, Jacob E, Schirrmacher V, Brunner G. Urokinase-type and tissue-type plasminogen activators are essential for in vitro invasion of human melanoma cells. Exp Cell Res 1991, 192:453-459. 10.1016/0014-4827(91)90064-2, 1899072.
34. Min J-K, Kim Y-M, Kim SW, Kwon M-C, Kong Y-Y, Hwang IK, Won MH, Rho J, Kwon Y-G. TNF-related activation-induced cytokine enhances leukocyte adhesiveness: induction of ICAM-1 and VCAM-1 via TNF receptor-associated factor and protein kinase C-dependent NF-kappaB activation in endothelial cells. J Immunol 2005, 175:531-540.
35. Long EO. ICAM-1: getting a grip on leukocyte adhesion. J Immunol 2011, 186:5021-5023. 10.4049/jimmunol.1100646, 21505213.
36. Friedl P, Gilmour D. Collective cell migration in morphogenesis, regeneration and cancer. Nat Rev Mol Cell Biol 2009, 10:445-457. 10.1038/nrm2720, 19546857.
37. Liang S, Hoskins M, Dong C. Tumor cell extravasation mediated by leukocyte adhesion is shear rate dependent on IL-8 signaling. Mol Cell Biomech 2010, 7:77-91. 2850573, 20379392.
38. Kato Y, Zhang LU, Pili R. Endothelial cells promote metastatic melanoma cell invasion via alpha(v)beta(3) integrin. AACR Meeting Abstracts 2005, 2005:889.
39. Witkowska AM, Borawska MH. Soluble intercellular adhesion molecule-1 (sICAM-1): an overview. Eur Cytokine Netw 2004, 15:91-98.
40. Yamada M, Yanaba K, Takehara K, Sato S. Clinical significance of serum levels of soluble intercellular adhesion molecule-1 and soluble L-selectin in malignant melanoma. Arch Dermatol Res 2005, 297:256-260. 10.1007/s00403-005-0605-5, 16222535.
41. Giavazzi R, Foppolo M, Dossi R, Remuzzi A. Rolling and adhesion of human tumor cells on vascular endothelium under physiological flow conditions. J Clin Invest 1993, 92:3038-3044. 10.1172/JCI116928, 288509, 7504697.
42. Baton F, Deruyffelaere C, Chapin M, Prod'homme T, Charron D, Al-Daccak R, Alcaide-Loridan C. Class II transactivator (CIITA) isoform expression and activity in melanoma. Melanoma Res 2004, 14:453-461. 10.1097/00008390-200412000-00004, 15577315.
43. Martins I, Deshayes F, Baton F, Forget A, Ciechomska I, Sylla K, Aoudjit F, Charron D, Al-Daccak R, Alcaide-Loridan C. Pathologic expression of MHC class II is driven by mitogen-activated protein kinases. Eur J Immunol 2007, 37:788-797. 10.1002/eji.200636620, 17304627.
44. Martins I, Sylla K, Deshayes F, Lauriol J, Ghislin S, Dieu-Nosjean M-C, Viguier M, Verola O, Charron D, Alcaide-Loridan C, Al-Daccak R. Coexpression of major histocompatibility complex class II with chemokines and nuclear NFkappaB p50 in melanoma: a rational for their association with poor prognosis. Melanoma Res 2009, 19:226-237. 10.1097/CMR.0b013e32832e0bc3, 19574933.
45. Sargiannidou I, Qiu C, Tuszynski GP. Mechanisms of thrombospondin-1-mediated metastasis and angiogenesis. Semin Thromb Hemost 2004, 30:127-136.